05 Compliance

The regulatory file for vitamin K2 MK-4 oil

Technical document 05 · Reviewed 2026-11-20 · Vitamin K2 MK-4 Oil

On this page
  1. Four questions, one folder
  2. European Union
  3. United States
  4. United Kingdom
  5. The limits in the file
  6. Where the claim boundary sits
  7. The document set
  8. A short checklist

Vitamin K2 MK-4 is menaquinone-4, CAS 863-61-6, supplied as a 1% oil in a declared carrier. The EU novel-food entry for vitamin K2 rests on menaquinone-7, so an MK-4 oil does not inherit that file, and the route for the destination has to be confirmed by the buyer's regulatory team. The checks and documents below are what the folder should contain; this page is not a legal opinion.

In one line

The MK-7 novel-food entry does not cover an MK-4 oil, so the route, the carrier declaration and the label are confirmed for the destination before the order.

Four questions, one folder

A regulatory file answers four separate questions. Does the substance, at this dose, have a route into the market? Does the lot meet the specification that route names? Does the label carry the permitted name, unit and declarations? And is every claim on the pack allowed for this ingredient and this market? A certificate speaks only to the second.

For an oil there is a fifth item inside the first question: the carrier. The bottle is not menaquinone-4 alone; it is a blend of the menaquinone with a food-grade oil, and that oil is an ingredient in its own right. It must be permitted for the use, declared on the label, and covered by the allergen and GMO statements. A file that names only MK-4 has described part of the product.

European Union

Regulation (EU) 2017/2470 establishes the Union list of novel foods. The vitamin K2 entry is framed around menaquinone-7, with an assay range, an all-trans floor and a cap on cis isomers; its description of the homologous series reaches the MK-4 formula. Whether an MK-4 ingredient can lean on that entry, or needs a different route, is for the buyer's regulatory team to decide against the consolidated text; this summary is not the authority.

Food supplements follow a separate framework: Directive 2002/46/EC names vitamin K among the vitamins that may be used and lists permitted forms in its annexes. Whether this particular form can be sold as a vitamin depends on the current text and the member state's own rules. The carrier oil needs its own permission as a food ingredient, and any national position on the menaquinone belongs in the file as well.

Dose is part of the review. The EU reference value for vitamin K is 75 µg; a 45 µg serving is 60% of it, while a 5 mg serving is more than 6,000% of it. The same substance at those two doses is not the same regulatory question.

United States

In the United States, an MK-4 oil sits in the dietary-supplement market under DSHEA. The supplier states whether the ingredient was marketed before 15 October 1994 or is supported by a new dietary ingredient notification, and the buyer checks that the basis reaches the finished product. cGMPs for dietary supplements sit in 21 CFR 111, and the panel layout in 21 CFR 101.36.

Vitamin K is declared in micrograms on that panel, so a 5 mg serving appears as 5,000 µg, which is more than 4,000% of the 120 µg daily value. That is a unit conversion, not a different dose, and it is the kind of figure a reviewer notices. The carrier oil appears in the ingredient list, and a soy-derived carrier brings an allergen review and a GMO statement with it.

United Kingdom

Great Britain keeps its own retained novel-food list and its own supplement and labelling rules. The GB list began as a copy of the EU list but can drift as either side amends its text, so it needs its own check. Northern Ireland follows EU rules under the Windsor Framework, and a GB-only review leaves that market uncovered.

The limits in the file

Catalog limits and what the compliance file should show
ItemCatalog limitEvidence for the file
Heavy metalsPb ≤3 · As ≤2 · Cd ≤1 · Hg ≤0.1 mg/kgMeasured result per element, method and finished-product calculation
Peroxide value≤10.0 meq O₂/kgMeasured figure with the test date and the in-use period
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentMethod and count for the lot
Carrier identityThe declared food-grade oilFatty-acid profile, carrier source and allergen statement

The table gives catalog release limits; it does not say that every market applies the same legal ceiling. Contaminant limits are set per destination, and the finished-product figure depends on the dose. Peroxide value is a quality limit rather than a legal one, but a market review of an oxidised oil still reviews the product as sold.

Where the claim boundary sits

For the EU, nutrition and health claims sit under Regulation (EC) No 1924/2006 and the EU Register, as of this review. A wording is usable only if it is on the Register, matches the conditions of use and avoids a disease claim. Vitamin K does appear on the Register, but no wording is quoted or relied on here; the brand's reviewer decides what is available for its product, form and dose.

“Menaquinone-4”, “MK-4” and the assay figure are specification terms, not claims. In the US the claim review follows the structure/function boundary, with the DSHEA disclaimer and no disease claim. A wording cleared in one country is not cleared in another, and revising a claim does not reopen the specification.

The document set

Documents a brand should hold for an MK-4 oil lot
DocumentWhat it should establish
Certificate of analysisLot code, concentration and method, peroxide value, contaminants, microbiology
SpecificationThe release limits the certificate is judged against
Technical data sheetConcentration, carrier, solubility, pack and storage
Safety data sheetHandling, transport and storage classification
Allergen and GMO statementsThe carrier source and any declaration the market requires
Carrier source statementWhich oil, from which source, under which specification
Regulatory position statementHow the ingredient maps to the route relied on for the destination

A short checklist

  • Does the file name menaquinone-4, the CAS number and the carrier?
  • Does the certificate meet the specification on its stated basis?
  • Is the route confirmed for the destination and the daily dose?
  • Is the carrier permitted and declared for that market?
  • Is the label using the permitted name and unit for that market?
  • Is every claim on the pack permitted for this form and market?
  • Is the same lot code on the COA, the bottle label and the retained sample?

The specification is on the product page, the certificate on the COA page, the grade question on the grades page, and the other menaquinone form on the MK-4 powder page. Framework references are gathered in the EU regulatory notes, and the quality page covers release.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation